Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  6.00 1.58% 386.00 386.00 396.00 394.00 370.00 380.00 118,043 16:19:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -20.5 -26.2 - 301

Silence Therapeutics Share Discussion Threads

Showing 50476 to 50499 of 50925 messages
Chat Pages: Latest  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  Older
DateSubjectAuthorDiscuss
24/1/2019
15:27
Av now 112p
volsung
24/1/2019
15:27
Bought some more at 48.72p Looks like I'm going down with the ship!
volsung
24/1/2019
15:13
With all this selling still no holding rns?
djnzloop
16/1/2019
13:29
Just what I was thinking!
brad1
15/1/2019
20:08
Imagine if we had a bad RNS... may have ended up a green day
viku111
15/1/2019
08:12
Aye......... :)
soundbuy
15/1/2019
07:38
I suppose thats quite a nice rns
volsung
09/1/2019
07:40
Amicable enough outgoing comment.......zzzzzzz
soundbuy
09/1/2019
07:07
That rns is not encouraging. There seems to be a disturbingly high turnover rate in the c-suite.
1gw
05/1/2019
12:47
Quark trial seems to be completed. Updated yesterday. QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant (ReGIFT)
waterloo01
28/12/2018
12:23
Bought some more. Av now 119p
volsung
19/12/2018
11:03
"Silence Therapeutics said that an Investigational New Drug/Clinical Trials Application for SLN360 is anticipated to be filed in the second half of 2020. In a note to clients, analysts at ‘house’ broker Peel Hunt said: “We see this as a positive step for the company as new management focus much more on the building the pipeline – adding this to the Silence’s asset for beta-thalassemia and myelodysplastic syndrome (SLN124).” They added: “We continue to review our valuation methodology following resolution of the recent litigation but this asset will add NPV to the portfolio/platform on a risk-adjusted basis.” In mid-morning trading, Silence Therapeutics’ shares were 0.7% higher at 55.20p"
callumross
18/12/2018
13:19
Thought the Quark QPI2002 phase 3 results were out today
callumross
14/12/2018
20:35
Here's the new CEO earlier todayhttps://www.youtube.com/watch?v=j-p1fzOPQQw&feature=youtu.beI found this vague, unfocused & uninspiring. I'm only hanging in there on the sale rumour & ex CEO large buyNot seen an update on the Peel Hunt stance yet...
djnzloop
13/12/2018
17:04
As long as it's proportional. Still take some hope that a deal is going on in the background, especially given the ex CEO purchase at higher price but I've never particularly likes the company as it's proven a serial disappointment. At least it's funded so that's OK.
waterloo01
13/12/2018
16:50
Probably wise waterloo. This one is an experiment for me. Add a couple of hundred pounds worth every time it tanks.
volsung
13/12/2018
16:46
Not me. I won't chase it down further, rarely sensible (despite a small buy today my holding is only about 0.5% of PF). Whenever I look at the stocks that have completely bombed, I always ask myself, afterwards, why I didn't sell when it was just 15%/20% down? Wish I had a consistent answer to that one,
waterloo01
13/12/2018
16:41
Reckon we’ll pick up some in the 40s soon
volsung
13/12/2018
16:27
Spoke too soon.
waterloo01
13/12/2018
16:12
Bought some more. Av now 127.64
volsung
13/12/2018
15:55
Well that was a punt that's gone wrong, so far. Just clinging on in the hope that either the Quark results are good or a buyer appears, but the share price doesn't suggest it after the media rumours.
waterloo01
13/12/2018
12:45
& then how long to burn the cash? If they went for it a couple of years ??
djnzloop
13/12/2018
12:16
Cheaper by the day.......parity with net cash looms.......enterprise value zero?
soundbuy
10/12/2018
16:49
That was a nice jump from the low indeed
volsung
Chat Pages: Latest  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  Older
Your Recent History
LSE
SLN
Silence Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191113 05:26:54